Host acid sphingomyelinase regulates microvascular function not tumor immunity

Monica Garcia-Barros1, Daniel Lacorazza, Howard Petrie

  • 1Laboratory of Signal Transduction, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Cancer Research
|November 19, 2004
PubMed

Insights

Tumor growth and radiation resistance in acid sphingomyelinase (asmase)-deficient mice are not due to immune response differences. These patterns are linked to the tumor endothelium's ability to undergo ASMase-mediated apoptosis.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Previous studies suggested acid sphingomyelinase (asmase) deficiency impacts tumor growth and radiation response.
  • Hypotheses included differences in host antitumor immunity or tumor microvascular endothelium apoptosis.

Purpose of the Study:

  • To investigate whether immune responses or tumor endothelial cell apoptosis mediate observed differences in tumor growth and radioresponsiveness in asmase-deficient mice.
  • To definitively link tumor growth and radiation response patterns to specific mechanisms.

Main Methods:

  • Tumor implantation (MCA/129 fibrosarcoma, B16 melanoma) into asmase-deficient and wild-type mice.
  • Assessment of tumor immunogenicity via infiltrates.
  • Tumor growth and radioresponsiveness evaluation in immune-deficient mouse models (Rag-/-, MEF(-/-)).
  • Analysis of immune cell populations (B, T, NK) in asmase-deficient mice.

Main Results:

  • Tumor-host combinations lacked criteria for immunogenic tumors, showing minimal infiltrates.
  • No significant differences in tumor growth or radioresponsiveness were observed in immune-deficient mouse models.
  • Immune cell populations in asmase-deficient mice were normal and comparable to wild-type littermates.
  • MCA/129 fibrosarcomas and B16F1 melanomas did not elicit a host immune response in wild-type mice.

Conclusions:

  • The observed differences in tumor growth and radiation response are not attributable to a deficient host antitumor immune response in asmase-deficient mice.
  • The asmase(-/-) phenotype does not exhibit a deficiency in antitumor immunity.
  • Tumor growth and radiation response are conditionally linked to the tumor endothelium's capacity for acid sphingomyelinase-mediated apoptosis.